Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. 
Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity.
Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan. 

Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF" data-destination="rte:bind">http://bit.ly/3vTiACF</a>. Bloomberg News Health Care Reporter Madison Muller discusses that patients taking Eli Lilly’s blockbuster weight-loss shot were 94% less likely to develop diabetes in a three-year study that illuminates the long-term health benefits of treating obesity. Hosts: Tim Stenovec and Katie Greifeld. Producer: Paul Brennan.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/0fc2301b-586e-4144-b6f9-b1d300c26c39/transcript

Featuring some of our favorite conversations of the week from our daily radio show “Bloomberg Businessweek Daily.”

Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. 

You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show &ldquo;Bloomberg Businessweek Daily.&rdquo; Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend: April 24th, 2026

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/eb6a3b87-8595-44c1-ab84-b4360148494e/transcript

The people, companies and trends shaping the global economy. 

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF 

The Justice Department is ending a controversial investigation into building-renovation cost overruns at the Federal Reserve, potentially clearing a path to confirmation for Kevin Warsh, President Donald Trump’s pick to be the next chair of the central bank. 

Jeanine Pirro, US Attorney for the District of Columbia, said in a social media post Friday the Fed’s Office of Inspector General had been asked to scrutinize the cost overruns. She said she expects a report soon on the findings. 

“I have directed my office to close our investigation as the IG undertakes this inquiry,” Pirro said in the post. “Note well, however, that I will not hesitate to restart a criminal investigation should the facts warrant doing so.” 

The Fed’s OIG is already conducting a review of the renovation of the central bank’s headquarters, which it opened last year at the request of Fed Chair Jerome Powell. US Treasuries edged slightly higher following the announcement, with shorter-dated notes leading gains as some traders bet a Warsh-led Fed would be more inclined to cut interest rates. The two-year yield fell five basis points to 3.78%. 

The White House said in a statement “American taxpayers deserve answers about the Federal Reserve’s fiscal mismanagement, and the Office of the Inspector General’s more powerful authorities best position it to get to the bottom of the matter.” 

Today’s show features: 
Michael McKee, Bloomberg News International Economics & Policy Correspondent 
Grindr CEO George Arison on earnings and the company sponsoring the White House Correspondent Dinner Event 
Joshua Green, Bloomberg Businessweek National Correspondent, on Thomas Massie Gaining Ground with MAGA Base 
Ian King, Bloomberg News US Semiconductor Reporter on Intel and Texas Instruments 
Barbara Humpton, CEO at USA Rare Earth

The people, companies and trends shaping the global economy.&nbsp;
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF&nbsp;
The Justice Department is ending a controversial investigation into building-renovation cost overruns at the Federal Reserve, potentially clearing a path to confirmation for Kevin Warsh, President Donald Trump&rsquo;s pick to be the next chair of the central bank.&nbsp;
Jeanine Pirro, US Attorney for the District of Columbia, said in a social media post Friday the Fed&rsquo;s Office of Inspector General had been asked to scrutinize the cost overruns. She said she expects a report soon on the findings.&nbsp;
&ldquo;I have directed my office to close our investigation as the IG undertakes this inquiry,&rdquo; Pirro said in the post. &ldquo;Note well, however, that I will not hesitate to restart a criminal investigation should the facts warrant doing so.&rdquo;&nbsp;
The Fed&rsquo;s OIG is already conducting a review of the renovation of the central bank&rsquo;s headquarters, which it opened last year at the request of Fed Chair Jerome Powell. US Treasuries edged slightly higher following the announcement, with shorter-dated notes leading gains as some traders bet a Warsh-led Fed would be more inclined to cut interest rates. The two-year yield fell five basis points to 3.78%.&nbsp;
The White House said in a statement &ldquo;American taxpayers deserve answers about the Federal Reserve&rsquo;s fiscal mismanagement, and the Office of the Inspector General&rsquo;s more powerful authorities best position it to get to the bottom of the matter.&rdquo;&nbsp;
Today&rsquo;s show features:&nbsp;
<ul>
<li>Michael McKee, Bloomberg News International Economics &amp; Policy Correspondent&nbsp;</li>
<li>Grindr CEO George Arison on earnings and the company sponsoring the White House Correspondent Dinner Event&nbsp;</li>
<li>Joshua Green, Bloomberg Businessweek National Correspondent, on Thomas Massie Gaining Ground with MAGA Base&nbsp;</li>
<li>Ian King, Bloomberg News US Semiconductor Reporter on Intel and Texas Instruments&nbsp;</li>
<li>Barbara Humpton, CEO at USA Rare Earth</li>
</ul>

DOJ Drops Powell Probe, Smoothing Path for Warsh to Lead Fed

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2cacdb64-fc16-4af2-9632-b4360171900b/transcript

Doug Lucas, is a double board-certified physician in Orthopedic Surgery and in Anti-Aging & Regenerative Medicine, specializing in Osteoporosis Reversal, Hormone Replacement, and HealthSpan optimization. After completing his training at Stanford University and practicing nearly a decade as an orthopedic surgeon, Dr. Doug left surgery to pursue an additional fellowship and board certification in Anti-Aging and Regenerative Medicine.

Dr. Doug shares his passion for education and disease prevention. While he champions health and hormone optimization for all, his mission is especially focused on educating the world that osteoporosis is both preventable. He speak with Bloomberg's Carol Massar and Tim Stenovec.

Doug Lucas, is a double board-certified physician in Orthopedic Surgery and in Anti-Aging &amp; Regenerative Medicine, specializing in Osteoporosis Reversal, Hormone Replacement, and HealthSpan optimization. After completing his training at Stanford University and practicing nearly a decade as an orthopedic surgeon, Dr. Doug left surgery to pursue an additional fellowship and board certification in Anti-Aging and Regenerative Medicine.
Dr. Doug shares his passion for education and disease prevention. While he champions health and hormone optimization for all, his mission is especially focused on educating the world that osteoporosis is both preventable. He speak with Bloomberg's Carol Massar and Tim Stenovec.

Women Lose Significant Bone Density During Menopause

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/cc9d7fbe-8d0d-44db-8394-b435016b9f5a/transcript

Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips